Taking aim at islet hormones with GLP-1: is insulin or glucagon the better target?
D'Alessio
David A
DA
Division of Endocrinology, Diabetes and Metabolism, University of Cincinnati, Cincinnati VA Medical Center, Cincinnati, Ohio, USA. dalessd@ucmail.uc.edu
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism; D005934:Glucagon / Q000378:metabolism*; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007328:Insulin / Q000378:metabolism*
D007328:Insulin; D052216:Glucagon-Like Peptide 1; D005934:Glucagon